TRIO – Canada’s First Lab to Adopt Violet

January 8, 2021

Violet™ is a non-invasive, AI-based software tool that assesses and analyzes images of a patient’s eggs to predict the chances of each egg to successfully fertilize and reach the blastocyst stage. Social egg freezing patients at TRIO will receive a complete report on each of their frozen eggs, along with an analysis of the quality of each egg and its likelihood to become a blastocyst when fertilized. TRIO is the first clinic in Canada to offer this technology to our social egg freezing patients.

visit TRIO’s website

 

Related posts

March 18, 2019

How California Became the World’s Fertility Treatment Destination

In the serene, sunlight-filled waiting room of California Fertility Partners in Los Angeles—one of the world’s leading practitioners of in-vitro [...]
February 14, 2019

IVF coverage by employers on the rise? How to know what your company offers?

Infertility coverage is the in-demand benefit of the moment for women and more companies are stepping up to offer to [...]
April 30, 2019

Future Fertility Launches First AI Image Analysis Tool to Evaluate Women’s Eggs

TORONTO, April 30, 2019 /CNW/ — Future Fertility Inc, an AI biotech startup focusing on reproductive innovation has developed a non-invasive image [...]